Preclinical Imaging Industry Overview
The global preclinical imaging market size was valued at USD 3.25 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 3.8% from 2022 to 2030. The growing number of investments and funding in research and development coupled with the constant pace of technological advancements leading to the development of hybrid imaging systems is primarily driving the growth of the market. Preclinical research is transforming how modern medicine is delivered as well as how health problems are treated and resolved. Preclinical imaging techniques include the reduction of biological variability and the ability to acquire an impressive amount of unique information in distinct forms as well as a significant reduction in the number of animals required for a particular study, fully complying with 3R (Replacement, Reduction, and Refinement) policies.
Furthermore, the increasing number of Clinical Research Organizations (CROs) and pharmaceutical companies are increasing the adoption of in-vivo imaging systems in preclinical research, which is further expected to accelerate the growth of this market for preclinical imaging. For instance, in July 2020, the USF Health Morsani College of Medicine, installed the new 7T-3T MR/PET and PET-CT systems by MR solutions, to establish their first comprehensive preclinical imaging suite. On the other hand, the restrictions placed on animal testing due to regulations enforced by organizations, which protect animal rights are the major factors impeding the growth of the market.
Gather more insights about the market drivers, restraints, and growth of the Global Preclinical Imaging market
As a result, the adoption of alternative methods such as in-vitro tests, micro-dosing, computer-based models, virtual testing of new drugs, and the development of computerized databases for testing purposes is rapidly increasing. However, modalities with non-invasive imaging techniques such as MRI and CT scans are making their way in the market. The COVID 19 outbreak, in 2020, had a considerable influence on the market, resulting in a drop in preclinical imaging device manufacturing as well as delays in the import and export of devices, creating extensive business disruption. However, the market is gradually returning back to normal as national lockdowns and sales banned have been lifted. For instance, Bruker's revenues fell by 4.1 percent in 2020, however orders and revenues recovered sequentially in the second half of the year as business circumstances improved.
Browse through Grand View Research's Pharmaceuticals Industry Research Reports.
Point-of-Care Medical Imaging Market - The global point-of-care medical imaging market was valued at USD 1.21 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 4.3% from 2023 to 2030.
Non-invasive Coronary Imaging Market - The global non-invasive coronary imaging market size was valued at USD 0.142 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2023 to 2030.
Preclinical Imaging Market Segmentation
Grand View Research has segmented the global preclinical imaging market based on product, application, end use and region:
Preclinical Imaging Product Outlook (Revenue, USD Million, 2017 - 2030)
- CT Imaging
- MRI Imaging
- PET/SPECT Imaging
- Multi-modal Imaging
- Optical Imaging
- Ultrasound Imaging
- Photoacoustic (PAT) Imaging
- Reagents
- Services
Preclinical Imaging Market, Application Outlook (Revenue, USD Million, 2017 - 2030)
- Research and Development
- Drug Discovery
Preclinical Imaging Market, End Use Outlook (Revenue, USD Million, 2017 - 2030)
- Biotech Companies
- Pharmaceutical companies
- Research institutes
Preclinical Imaging Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
Market Share Insights:
November 2021: Bruker Corporation acquired MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging systems. This acquisition is expected to strengthen Bruker's position as a leading supplier in preclinical and translational imaging research.
Key Companies profiled:
Some prominent players in the global Preclinical Imaging market include:
- Bruker Corporation
- Siemens A.G.
- General Electric (GE)
- TriFoil Imaging
- PerkinElmer, Inc.
- VisualSonics Inc. (Fujifilm)
- Mediso Ltd.
- Agilent Technologies
- MILabs B.V.
- MR Solutions
- Molecubes
Order a free sample PDF of the Preclinical Imaging Market Intelligence Study, published by Grand View Research.
No comments:
Post a Comment